首页> 外国专利> Reducing cholesterol levels in body fluids and tissues e.g. human blood, by administration of pentaerythritol mono-, di-, tri- or tetranitrate

Reducing cholesterol levels in body fluids and tissues e.g. human blood, by administration of pentaerythritol mono-, di-, tri- or tetranitrate

机译:降低体液和组织中的胆固醇水平,例如人血,通过季戊四醇单,二,三或四硝酸酯的施用

摘要

Pentaerythritol mono-, di-, tri- or tetranitrate (I) is used for reducing the cholesterol concentration in the tissues and fluids of organisms. Independent claims are also included for: (i) Pentaerythritol mono-, di-, tri- or tetranitrate (I)-containing pharmaceutical compositions for reducing the cholesterol concentration in the tissues and fluids of the human organism; and (ii) the use of (I) for the preparation of compositions as in (i). - ACTIVITY : Antilipemic. In tests in guinea pigs, addition of 0.5% cholesterol to the feed over 2 months induced a ca. 6-fold increase in cholesterol level (control group). If 6 mg/kg per day of pentaerythritol tetranitrate (Ia) was additionally added to the feed, the cholesterol level was reduced by more than 30% relative to the control group. - MECHANISM OF ACTION : None given in the source material.
机译:季戊四醇单,二,三或四硝酸盐(I)用于降低生物体组织和体液中的胆固醇浓度。还包括以下方面的独立权利要求:(i)含有季戊四醇单,二,三或四硝酸盐(I)的药物组合物,用于降低人体组织和体液中的胆固醇浓度; (ii)(I)在制备(i)中的组合物中的用途。 -活动:抗血脂。在豚鼠的试验中,在2个月内向饲料中添加0.5%的胆固醇会引起约5%的胆固醇。胆固醇水平提高了6倍(对照组)。如果每天向饲料中添加6 mg / kg的季戊四醇四硝酸盐(Ia),则相对于对照组,胆固醇水平降低了30%以上。 -作用机理:原始资料中未提供。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号